The benefit of the control of this enzyme includes a decrease in Angiotensin II concentrations and an increase in the vasodilator Bradykinin, the combination of which results in a reduction in hypertension or high blood pressure [24,25,26]. Here, KNG1 is linked to hypertensive disorder.